Lung Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Lung Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-03-27Clinical Trial Update: Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma
This clinical trial update describes evaluating circulating tumor DNA (ctDNA) as a prognostic biomarker in patients with advanced lung adeno…
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP)
Clinical trial update analyzing ALK rearrangements in lung adenocarcinoma; focusing on epidemiology in Latin America.
-
CLINICAL_TRIALS research · 2017-02-24Clinical Trial Update: Blood Detection of EGFR Mutation For Iressa Treatment [NA]
This clinical trial update covers blood-based detection of EGFR mutations to guide Iressa (gefitinib) therapy in lung adenocarcinoma. The tr…
-
CLINICAL_TRIALS research · 2017-01-24Clinical Trial Update: Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis
A clinical trial sponsored by Shandong Cancer Hospital and Institute is evaluating cerebrospinal fluid next-generation sequencing for detect…
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial [Phase 2]
A Phase 2 randomized trial evaluating whether adding gefitinib to chemotherapy improves outcomes in advanced lung adenocarcinoma with sensit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-09-13Clinical Trial Update: Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma
This clinical trial update discusses chemoresistance and involvement of the NOTCH signaling pathway in patients with lung adenocarcinoma.
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Molecular Analysis of 150 Lung Adenocarcinoma
Clinical trial update describing molecular analysis of 150 lung adenocarcinoma samples.
-
CLINICAL_TRIALS research · 2016-06-21Clinical Trial Update: Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma [Phase 4]
A Phase 4 clinical trial update describing Endostar (recombinant human endostatin) given with chemotherapy for advanced lung adenocarcinoma;…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test
Study exploring whether plasma free nucleic acids EGFR mutation testing can predict gefitinib efficacy in lung adenocarcinoma.
-
CLINICAL_TRIALS research · 2016-03-10Clinical Trial Update: Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating erlotinib (Tarceva) with or without apatinib in advanced lung adenocarcinoma. The status of the trial is n…
-
CLINICAL_TRIALS research · 2016-02-05Clinical Trial Update: The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR [Phase 2]
Phase 2 clinical trial evaluating apatinib plus cytokine-induced killer (CIK) cells as third-line therapy for advanced lung adenocarcinoma.
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2 [NA]
Clinical trial update describing a study comparing chemoradiation with sequential chemoradiation in postoperative pN2 lung cancer patients, …
-
CLINICAL_TRIALS research · 2015-04-29Clinical Trial Update: Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma [Phase 4]
A Phase 4 trial is evaluating whether adding sequential chemotherapy to icotinib improves first-line treatment outcomes for stage IIIB/IV EG…
-
CLINICAL_TRIALS research · 2014-11-03Clinical Trial Update: Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma [Phase 3]
A Phase 3 multicenter randomized trial evaluating adjuvant chemotherapy versus observation in patients with stage Ib lung adenocarcinoma.
-
CLINICAL_TRIALS research · 2014-07-18Clinical Trial Update: Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC [Phase 4]
A Phase 4 clinical trial from Betta Pharmaceuticals compares sequential and maintenance icotinib plus chemotherapy with icotinib maintenance…
-
CLINICAL_TRIALS research · 2013-09-16Clinical Trial Update: Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas
This clinical trial update examines the prognostic value of the P63 marker in adenocarcinomas of the lung, breast, and pancreas, with the cu…
-
CLINICAL_TRIALS research · 2013-01-24Clinical Trial Update: Molecular Epidemiology of Lung Adenocarcinoma in Multi-ethnic Asian Phenotype [NA]
An ongoing molecular epidemiology study of lung adenocarcinoma in a multi-ethnic Asian population, sponsored by National University Hospital…
-
CLINICAL_TRIALS research · 2011-11-30Clinical Trial Update: Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
A Samsung Medical Center-sponsored clinical trial update on early-stage lung adenocarcinoma aimed at improving early detection and treatment…
-
CLINICAL_TRIALS research · 2010-11-29Clinical Trial Update: Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma
This clinical trial update examines the expression of optic atrophy type 1 (OPA1) protein in lung adenocarcinoma.
-
CLINICAL_TRIALS research · 2010-11-29Clinical Trial Update: Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
A clinical trial update examining the expression of AMP-activated Protein Kinase (AMPK) protein in lung adenocarcinoma; current trial status…
-
CLINICAL_TRIALS research · 2010-05-27Clinical Trial Update: A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations [Phase 2]
A Phase 2 randomized crossover trial in untreated EGFR-mutant stage IIIB/IV lung adenocarcinoma compares erlotinib with docetaxel/cisplatin.
-
CLINICAL_TRIALS research · 2009-05-18Clinical Trial Update: Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma [NA]
This clinical trial update describes a study investigating EGFR mutation–guided second-line therapy for patients with advanced lung adenocar…